William Blair Forecasts Lower Earnings for Aehr Test Systems

Aehr Test Systems (NASDAQ:AEHRFree Report) – Equities researchers at William Blair cut their FY2025 EPS estimates for Aehr Test Systems in a research report issued on Wednesday, April 9th. William Blair analyst J. Dorsheimer now anticipates that the semiconductor company will post earnings per share of $0.00 for the year, down from their previous forecast of $0.10. The consensus estimate for Aehr Test Systems’ current full-year earnings is $0.10 per share. William Blair also issued estimates for Aehr Test Systems’ Q4 2025 earnings at ($0.04) EPS, Q1 2026 earnings at ($0.01) EPS, Q3 2026 earnings at $0.00 EPS, Q4 2026 earnings at $0.00 EPS and FY2026 earnings at ($0.01) EPS.

Aehr Test Systems (NASDAQ:AEHRGet Free Report) last posted its quarterly earnings results on Monday, January 13th. The semiconductor company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Aehr Test Systems had a return on equity of 21.09% and a net margin of 43.41%.

Separately, StockNews.com upgraded shares of Aehr Test Systems to a “sell” rating in a report on Wednesday, January 22nd.

Check Out Our Latest Research Report on AEHR

Aehr Test Systems Trading Up 2.9 %

Shares of NASDAQ AEHR opened at $8.54 on Monday. The stock has a market capitalization of $253.74 million, a PE ratio of 11.39 and a beta of 2.00. Aehr Test Systems has a 12-month low of $6.27 and a 12-month high of $21.44. The stock’s fifty day simple moving average is $9.17 and its two-hundred day simple moving average is $11.91.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. raised its stake in Aehr Test Systems by 2.1% in the 4th quarter. Vanguard Group Inc. now owns 2,183,641 shares of the semiconductor company’s stock worth $36,314,000 after acquiring an additional 44,881 shares during the last quarter. Baillie Gifford & Co. increased its stake in shares of Aehr Test Systems by 12.0% in the fourth quarter. Baillie Gifford & Co. now owns 2,023,559 shares of the semiconductor company’s stock worth $33,652,000 after acquiring an additional 216,710 shares during the period. Point72 Asset Management L.P. purchased a new position in shares of Aehr Test Systems during the fourth quarter worth $15,307,000. Geode Capital Management LLC lifted its position in Aehr Test Systems by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 647,610 shares of the semiconductor company’s stock valued at $10,773,000 after purchasing an additional 8,461 shares during the period. Finally, Rice Hall James & Associates LLC grew its position in Aehr Test Systems by 59.1% during the 4th quarter. Rice Hall James & Associates LLC now owns 634,391 shares of the semiconductor company’s stock worth $10,550,000 after purchasing an additional 235,625 shares during the period. Institutional investors and hedge funds own 69.69% of the company’s stock.

Aehr Test Systems Company Profile

(Get Free Report)

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.

Further Reading

Earnings History and Estimates for Aehr Test Systems (NASDAQ:AEHR)

Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.